Patents Assigned to Yissum Research and Development Corporation of the Hebrew University of Jerusalem
  • Synthesizing virtual two dimensional images of three dimensional space from a collection of real two dimensional images
    Patent number: 6219444
    Abstract: Method and apparatus are provided for generating two dimensional images representing scenes of three dimensional spaces as viewed for arbitrary observing point. In a specific embodiment of the method and apparatus, consecutive virtual images, computed from four dimensional reference images are consecutively displayed on a multimedia screen in order to convey motion of a body.
    Type: Grant
    Filed: February 2, 1998
    Date of Patent: April 17, 2001
    Assignee: Yissum Research Development Corporation of the Hebrew University of Jerusalem
    Inventors: Amnon Shashua, Shai Avidan
  • Derivatives of valproic acid amides and 2-valproenoic acid amides, method of making and use thereof as anticonvulsant agents
    Patent number: 5585358
    Abstract: A compound having the structure: ##STR1## wherein R.sub.1, R.sub.2, and R.sub.3 are independently the same or different and are hydrogen, a C.sub.1 -C.sub.6 alkyl group, an aralkyl group, or an aryl group, and n is an integer which is greater than or equal to 0 and less than or equal to 3. Also provided are a compound containing a 2-valproenoic moiety, pharmaceutical compositions comprising these compounds, and methods of using them for the effective treatment of epilepsy and other neurological disorders.
    Type: Grant
    Filed: July 6, 1993
    Date of Patent: December 17, 1996
    Assignees: Yissum Research Development Corporation of the Hebrew University of Jerusalem, Teva Pharmaceutical Industries Ltd.
    Inventors: Meir Bialer, Salim Hadad, Jacob Herzig, Jeff Sterling, David Lerner, Mitchell Shirvan
  • Pharmaceutical composition for protecting the heart comprising a heterocyclic ethylenediamine derivative and methods for the use thereof
    Patent number: 5082851
    Abstract: The invention provides a composition for protecting the heart from myocardial ischemia and reperfusion injury as well as for reducing post-ischemic damage, improving cardiac function and serving as a hypothermic cardiac preservative solution comprising N,N,N'N'-tetrakis-(2-pyridylmethyl)-ethylenediamine (TPEN) as active ingredient therein.
    Type: Grant
    Filed: February 7, 1990
    Date of Patent: January 21, 1992
    Assignees: Hadassah Medical Organization, Yissum Research and Development Corporation of the Hebrew University of Jerusalem
    Inventors: Jerachmiel Y. Appelbaum, Mordechai Chevion, Gideon Uretzky